ArticleWorld journal of urology2024

Enzalutamide versus abiraterone acetate in the development of new-onset or worsening type 2 diabetes mellitus in patients with metastatic castration-resistant prostate cancer: EVADE study.

Amit Bahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.